BSE filing, NSE: BALGOPAL. Summary written from the filing by ALFA Finder's alert engine.
Balgopal Commercial Ltd: key numbers
- Share price
- ₹159.75
- Market cap
- ₹303.7 Cr
- Revenue (annual)
- ₹0.02 Cr
- Net profit (annual)
- ₹-8.85 Cr
- P/E (TTM)
- -56.5×Sector 36.4×
- Promoter holding
- 55.38%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balgopal Commercial Ltd
All →Balgopal Commercial ED Probe / Tax Survey
Balgopal Commercial Limited confirms that the Income Tax Department has concluded its search at company premises. No communication on potential financial impact has been received yet.
Balgopal Commercial Annual General Meeting
Balgopal Commercial Limited filed the Scrutinizer's Report and voting results for its 44th Annual General Meeting held on September 30, 2026.
Balgopal Commercial ED Probe / Tax Survey
Balgopal Commercial Limited reported an ongoing visit by Income Tax Department officials at its premises. Directors and senior management are currently attending to the proceedings with restricted communication.
Balgopal Commercial Board Meeting Outcome
Balgopal Commercial Limited approved a corrigendum to its AGM notice regarding a proposed name change to Dreamax Enterprises Limited. This update follows observations from BSE regarding the company's application.
Balgopal Commercial Annual General Meeting
Balgopal Commercial Limited issued a corrigendum to its AGM notice regarding a proposed name change to Dreamax Enterprises Limited. The update includes a revised Chartered Accountant's certificate.
Balgopal Commercial Annual Report
Balgopal Commercial Limited has filed its Annual Report and notice of the 44th Annual General Meeting for the financial year 2025-26 with the exchange.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.